News dal mondo
09
Mar
US FDA drafts guidance on best practices for responding to inspection observations
The US Food and Drug Administration (FDA) has released a draft guidance detailing how manufacturers should address Form 483 observations following a drug good manufacturing practice (GMP) inspection. This guidance applies to both domestic and international inspections. FDA is accepting comments on the draft guidance on www.regulations.gov under docket number FDA-2025-D-1504 through 6 May...[FDA]
The US Food and Drug Administration (FDA) has released a draft guidance detailing how manufacturers should address Form 483 observations following a drug good manufacturing practice (GMP) inspection. This guidance applies to both domestic and international inspections.
FDA is accepting comments on the draft guidance on www.regulations.gov under docket number FDA-2025-D-1504 through 6 May...[FDA]
13
Dal China all’India-shoring, il rischio di una nuova dipendenza
Una ricerca universitaria, promossa da CPA Italy, sulla supply chain di principi attivi e intermedi mostra...
11
EU Finalizes Pharma Reform Package, Clarifies New Rules On Modular Market Protection
A final version of the draft pharma reform package has been published, clarifying changes that the...
PFAS restriction proposal: ECHA’s Socio-Economic Analysis Committee agrees its draft opinion
The European Chemicals Agency’s Committee for Socio-Economic Analysis (SEAC) has agreed its draft opinion...
Farmaci - Gemmato: In cantiere anche un ritorno nazionale alla chimica farmaceutica di base
Il sottosegretario alla Salute Marcello Gemmato è intervenuto durante la presentazione del Rapporto...
le ultime news
21 Gen
Farmaci essenziali, via libera del Parlamento UE al Critical Medicines Act
12 Gen
AIFA - Direzione Uffici a strutture complesse dal 1 gennaio 2026
09 Gen
Bayer fa causa a Pfizer, Moderna e Biontech per violazione del brevetto vaccino Covid
02 Gen
Angelini Pharma: Amuchina e Infasil passano sotto il controllo di Fater
Manovra. Ok anche dalla Camera, il testo ora è legge. Novità per la Sanità
22 Dic
Massiccio reshoring farmaceutico negli Stati Uniti
17 Dic
EU health sector: New measures to make it more innovative, competitive and resilient
<<<4 5
